Deng, J., Wei, Y., Fonseca, V. R., Graca, L. & Yu, D. T follicular helper cells and T follicular regulatory cells in rheumatic diseases. Nat. Rev. Rheumatol. 15, 475–490 (2019).
Article PubMed CAS Google Scholar
Marks, K. E. & Rao, D. A. T peripheral helper cells in autoimmune diseases. Immunol. Rev. 307, 191–202 (2022).
Article PubMed PubMed Central CAS Google Scholar
Sato, Y., Silina, K., van den Broek, M., Hirahara, K. & Yanagita, M. The roles of tertiary lymphoid structures in chronic diseases. Nat. Rev. Nephrol. 19, 525–537 (2023).
Law, C. et al. Interferon subverts an AHR–JUN axis to promote CXCL13+ T cells in lupus. Nature 631, 857–866 (2024).
Article PubMed CAS Google Scholar
Basu, R. et al. Th22 cells are an important source of Il-22 for host protection against Enteropathogenic bacteria. Immunity 37, 1061–1075 (2012).
Article PubMed PubMed Central CAS Google Scholar
Kobayashi, S. et al. TGF-β induces the differentiation of human CXCL13-producing CD4+ T cells. Eur. J. Immunol. 46, 360–371 (2016).
Article PubMed CAS Google Scholar
Rutz, S., Eidenschenk, C. & Ouyang, W. IL-22, not simply a Th17 cytokine. Immunol. Rev. 252, 116–132 (2013).
Denton, A. E. et al. Type I interferon induces CXCL13 to support ectopic germinal center formation. J. Exp. Med. 216, 621–637 (2019).
Article PubMed PubMed Central CAS Google Scholar
Morand, E. F. et al. Trial of anifrolumab in active systemic lupus erythematosus. N. Engl. J. Med. 382, 211–221 (2020).
Article PubMed CAS Google Scholar
He, J. et al. Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus. Nat. Med. 22, 991–993 (2016).
留言 (0)